What this study is
The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors
What's being tested
- Individualized exercise program
Intervention · OTHER
guided exercise program for 12 weeks
- Control Arm
Intervention · OTHER
Control Arm Waiting List for 24 weeks, then offered a guided exercise program for 12 weeks
Study details
- Official title
- Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study
- Sponsor
- University of Michigan Rogel Cancer Center
- Conditions
- Breast Cancer Female
- Enrolling
- 75 people
- Starts
- 2024-05-28
- Est. completion
- 2026-12
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Self-identify as Black or African American or Afro-Latina/e;
- Are ≥18 years old;
- Have a confirmed diagnosis of breast cancer, Stage I to IIIA;
- Have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable;
- Are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and
- Are able to speak and understand English.
You can't join if
- Metastatic disease;
- Medical reason that precludes them from increasing current exercise levels;
- Planned elective surgery during study period;
- Pregnant or plans to become pregnant during the study period;
- Plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States);
- Current enrollment in another exercise trial; and/or
- Inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Michigan
Ann Arbor, Michigan, United States
- Cancer AnswerLine · Contact800-865-1125CancerAnswerLine@med.umich.edu
- Angela Fong, PhD · Principal investigator
Recruiting
Study team
Sponsor
University of Michigan Rogel Cancer Center
Study ID UMCC 2023.092
Principal investigator
Angela Fong, PhD
University of Michigan Rogel Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.